Gene · 70
Papers1,745
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,745
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical Implication of Genetic Testing in Dilated Cardiomyopathy. | Int J Heart Fail | 2022 | 36262197 | PubTator, text mining | PubMed |
| Cardiac-derived extracellular matrix: A decellularization protocol for heart regeneration. | PLoS One | 2022 | 36260645 | PubTator, text mining | PubMed |
| Generation and maturation of human iPSC-derived 3D organotypic cardiac microtissues in long-term culture. | Sci Rep | 2022 | 36257968 | PubTator, text mining | PubMed |
| Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization. | J Immunother Cancer | 2022 | 36252997 | PubTator, text mining | PubMed |
| The tumor microenvironment and prognostic role of autophagy- and immune-related genes in bladder cancer. | Cancer Biomark | 2022 | 36245371 | PubTator, text mining | PubMed |
| Understanding the extracellular vesicle surface for clinical molecular biology. | J Extracell Vesicles | 2022 | 36239734 | PubTator, text mining | PubMed |
| Triclosan and Its Consequences on the Reproductive, Cardiovascular and Thyroid Levels. | Int J Mol Sci | 2022 | 36232730 | PubTator, text mining | PubMed |
| Deciphering the Basis of Molecular Biology of Selected Cardiovascular Diseases: A View on Network Medicine. | Int J Mol Sci | 2022 | 36232723 | PubTator, text mining | PubMed |
| Identification and functional analysis of variants of MYH6 gene promoter in isolated ventricular septal defects. | BMC Med Genomics | 2022 | 36209093 | PubTator, text mining | PubMed |
| Identification and analysis of microRNA editing events in recurrent bladder cancer based on RNA sequencing: MicroRNA editing level is a potential novel biomarker. | Front Genet | 2022 | 36199571 | PubTator, text mining | PubMed |
| Cancer-associated fibroblast-derived gene signatures predict radiotherapeutic survival in prostate cancer patients. | J Transl Med | 2022 | 36195908 | PubTator, text mining | PubMed |
| Mechanism of Shishiwei Wendan Decoction in the Prevention and Treatment of Lung Adenocarcinoma Using Network Pharmacology and Molecular Docking. | Biomed Res Int | 2022 | 36193315 | PubTator, text mining | PubMed |
| Trogocytosis in innate immunity to cancer is an intimate relationship with unexpected outcomes. | iScience | 2022 | 36185368 | PubTator, text mining | PubMed |
| Genetic Evaluation of A Nation-Wide Dutch Pediatric DCM Cohort: The Use of Genetic Testing in Risk Stratification. | Circ Genom Precis Med | 2022 | 36178741 | PubTator, text mining | PubMed |
| Loss of full-length dystrophin expression results in major cell-autonomous abnormalities in proliferating myoblasts. | Elife | 2022 | 36164827 | PubTator, text mining | PubMed |
| Computational study of the impact of nucleotide variations on highly conserved proteins: In the case of actin. | Biophys Physicobiol | 2022 | 36160324 | PubTator, text mining | PubMed |
| Thin filament cardiomyopathies: A review of genetics, disease mechanisms, and emerging therapeutics. | Front Cardiovasc Med | 2022 | 36158814 | PubTator, text mining | PubMed |
| Genome-wide expression screening in the cardiac embryonic stem cell test shows additional differentiation routes that are regulated by morpholines and piperidines. | Curr Res Toxicol | 2022 | 36157598 | PubTator, text mining | PubMed |
| Identification of NHLRC1 as a Novel AKT Activator from a Lung Cancer Epigenome-Wide Association Study (EWAS). | Int J Mol Sci | 2022 | 36142605 | PubTator, text mining | PubMed |
| Assessment of a Large-Scale Unbiased Malignant Pleural Effusion Proteomics Study of a Real-Life Cohort. | Cancers (Basel) | 2022 | 36139528 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/70/papers?page=18